Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab in patients with Thyroid Eye Disease is active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Satralizumab (satralizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Thyroid Eye Disease, TED | Phase 3 | Status: ACTIVE_NOT_RECRUITING